Hong Kong Skyline
dicada | E+ | Getty Images
Regencell Bioscience HoltingsThis is an early stage without revenue, a Hong Kong-based bioscience company, the latest speculative overseas stock that can attract an unusual surge in trading demand.
Regencell’s stock said it developed traditional Chinese herbal treatments to treat children with attention deficit hyperactivity disorder and autism, more than tripled on Monday – soaring more than 280%. 38-1 point It will be effective on June 2. By the end of Monday, Regencell was founded in 2014 and has traded on the Nasdaq under the stock “RGC” since 2021, with a total market capitalization of $29.7 billion under the S&P Capital IQ.
The stock continued to increase on Tuesday, up more than 25%. The company’s annual performance to date is also not on the chart, growing by more than 58,000% in 2025. The current $36 billion market value is Lululemon, eBay and Kraft Heinz. Stocks have traded pennies at some point in the past year.
Regencell Bioscience Holtings in 2025.
Regencell is the latest example of speculative international stocks that has attracted attention in summer trading. For example, in August 2022, AMTD Numbersa fintech company located in Hong Kong, Climb 126%briefly give it market value greater than Coca Cola and Bank of America.
Earlier this month, Regencell explained the stock split, exactly “to enhance liquidity in the company’s common stock market and make it easier for investors to access stocks.” The stock split did not fundamentally change anything about the company.
Regencell’s surge also focused on alternative drugs after Robert F. Kennedy Jr. was sworn in in February. Vaccine skeptic Kennedy has taken steps Dissuading routine immunity Last week in the United States Delete all members of the panel This provides advice to the Centre for Vaccine Control and Prevention.
Regencell’s stock often performs a lot of swings a day. For example, stocks rose about 30% on March 21, and then fell 30% on the next trading day.
Obscure treatment, zero income
Despite the stock’s wild peaks, little is known about Reknell’s efficacy and commercialization of ADHD and autism spectrum disorders.
Regencel’s business focuses on proprietary traditional Chinese medicine formulas (TCM) in partnership with TCM practitioner Sik-Kee Au, using his “Sik-kee au tcm brain theory.“Sik-kee au is Reknell CEO’s father Yat-Gai Au, the company said in a 2022 statement.
According to FactSet data, the CEO controls 86.24% of the total outstanding shares.
Three liquid-based oral treatments TCM formula candidates Claiming to address mild, moderate and severe conditions, only natural ingredients such as so-called “detoxification herbs”, blood circulation herbs and digestive herbs.
“These TCM formulas form the basis for our TCM product candidates, and we intend to develop and commercialize them to treat ADHD and ASD,” Regencell’s website wrote.
In it Latest annual report submitted last OctoberRegencell said it generated no revenue and did not apply for any regulatory approval for its TCM formula. According to a 20F application filed with the U.S. Securities and Exchange Commission (SEC), Reginal caused net losses of $4.36 million and $6.06 million for fiscal years ending June 2024 and 2023, respectively.
“We have not yet earned income from any TCM formula candidates, have not applied for approval from any regulatory authorities, have no distribution capabilities or experience, or any granted patents or pending patent applications, and may never be profitable,” the document said.
Regencell has not responded to CNBC’s request for comment.
Regencell’s Latest patient case studyAccording to the company’s page, dated November 15, 2023, he said that in the second efficacy trial, 28 patients were treated within three months and showed improvements in ADHD and ASD symptoms.
In earlier cases, Regnell said in 2021 Press release It used a modified version of the AU’s modified proprietary cold and flu TCM formula to treat twelve suspected or confirmed cases of Covid-19. The statement said that one of the common conditions described as improved led to Rekneisel’s joint venture with Honor Epic Enterprises Limited in September 2021 for further testing and commercialization of the company’s shared treatment in ASEAN countries.
Online buzz
The stock has had little chat on social media over the past few years. Those comments posted show the enthusiasm and suspicion of retail traders.
A user on the Reddit page “R/Shortsqueeze” Regencell “trades like meme coins. Buy a little to see what happened and then drops 50% after laughing.” Another user said in an article published three months ago, “I scalp RGC every day to get some profit.” In May alone, the stock jumped 1,360%.
An investor said on LinkedIn in May that he “Can’t stop laughing“After reading the company’s description. Users in the pharmaceutical industryAccording to his profile, last week, Regnell has become a “stock to watch” after “no official news or catalyst” that surged in May. Last month, another LinkedIn user commented on Regencell, saying: “China, low capacity, no official news, Bizarro”.
One user wrote on X: ” #completebullsh__company of theyear I nominate Regencell. ”
– Scott Schnipper of CNBC contributed the report.
